Skip to main content
Cancer Medicine logoLink to Cancer Medicine
. 2020 Aug 28;9(20):7792. doi: 10.1002/cam4.3415

Corrigendum

PMCID: PMC7571825  PMID: 32857908

In the article by Li et al., 1 the published version of Table 4 is incorrect. Its content is identical with Table 5

The correct version of Table 4 is displayed below:

Table 4.

Analysis of DSS for histologic subtypes within specific DMS

Bone metastasis Brain metastasis Liver metastasis Lung metastasis
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Histology Type
IDC REF a REF REF REF
MBC 1.06(0.525‐2.14) .87 0.894 (0.318‐2.515) .832 0.949 (0.236‐3.823) .942 1.381 (0.895‐2.133) .145
Medullary b 2.812 (0.696‐11.357) .147
IDC and LC 1.202 (0.703‐2.054) .502 0.627 (0.197‐1.99) .428 0.804 (0.397‐1.629) .545 0.72 (0.23‐2.252) .572
LC 0.693 (0.43‐1.117) .132 1.438 (0.351‐5.884) .613 1.549 (0.764‐3.139) .225 3.787 (1.205‐11.905) .023
IDC and other 1.289 (0.574‐2.893) .539 0.528 (0.073‐3.801) .526 1.017 (0.377‐2.738) .974 0.534 (0.219‐1.298) .166
Apocrine 1.619 (0.403‐6.51) .497 3.772(0.525‐27.092) .187
Inflammatory 1.425 (0.861‐2.358) .169 1.282 (0.558‐2.945) .558 1.53(0.783‐2.989) .213 1.11(0.636‐1.936) .714

Bold indicates statistically significant value.

a

For calculation of HR value, a group of patients were defined as reference.

b

The number of patients was not enough for further calculation.

The authors apologize for this error.

REFERENCE

  • 1. Li Y, Su P, Wang Y, et al. Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer. Cancer Med. 2020;9:872–881. 10.1002/cam4.2759 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Medicine are provided here courtesy of Wiley

RESOURCES